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Ex Uno Plures: Clonal Reinforcement Drives Evolution of
a Simple Microbial Community
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Abstract
A major goal of genetics is to define the relationship between phenotype and genotype, while a major goal of ecology is to
identify the rules that govern community assembly. Achieving these goals by analyzing natural systems can be difficult, as
selective pressures create dynamic fitness landscapes that vary in both space and time. Laboratory experimental evolution
offers the benefit of controlling variables that shape fitness landscapes, helping to achieve both goals. We previously
showed that a clonal population of E. coli experimentally evolved under continuous glucose limitation gives rise to a
genetically diverse community consisting of one clone, CV103, that best scavenges but incompletely utilizes the limiting
resource, and others, CV101 and CV116, that consume its overflow metabolites. Because this community can be
disassembled and reassembled, and involves cooperative interactions that are stable over time, its genetic diversity is
sustained by clonal reinforcement rather than by clonal interference. To understand the genetic factors that produce this
outcome, and to illuminate the community’s underlying physiology, we sequenced the genomes of ancestral and evolved
clones. We identified ancestral mutations in intermediary metabolism that may have predisposed the evolution of
metabolic interdependence. Phylogenetic reconstruction indicates that the lineages that gave rise to this community
diverged early, as CV103 shares only one Single Nucleotide Polymorphism with the other evolved clones. Underlying
CV103’s phenotype we identified a set of mutations that likely enhance glucose scavenging and maintain redox balance,
but may do so at the expense of carbon excreted in overflow metabolites. Because these overflow metabolites serve as
growth substrates that are differentially accessible to the other community members, and because the scavenging lineage
shares only one SNP with these other clones, we conclude that this lineage likely served as an ‘‘engine’’ generating diversity
by creating new metabolic niches, but not the occupants themselves.
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Introduction
It is interesting to contemplate a tangled bank, clothed with many plants
of many kinds, with birds singing on the bushes, with various insects
flitting about, and with worms crawling through the damp earth, and to
reflect that these elaborately constructed forms, so different from each
other, and dependent upon each other in so complex a manner, have all
been produced by laws acting around us… Darwin, 1859
Illuminating the laws that produce Darwin’s ‘‘tangled bank’’
remains one of the great challenges of biology, one that requires
understanding how differences among forms are selected for, and
how interdependence among forms is generated. In natural
environments, meeting this challenge is complicated by the fact
that selection pressures often vary widely over both space and
time. Laboratory evolution experiments, in particular those using
microbes, offer an attractive alternative by which to study, under
controlled conditions, both the dynamic interplay between
genotype and phenotype as well as the interactions among
phenotypes in simple communities. Classical models of large
asexually evolving populations led to the expectation that in simple
environments complexity should be transient and limited in scope
[1,2]. Experimental evidence now suggests otherwise. Multiple
genotypes that arise from a single ancestral clone can coexist over
evolutionary time; in other words, ex uno plures (out of one many).
This phenomenon has been documented in spatially and
temporally unstructured chemostats [3,4], in temporally-struc-
tured batch cultures [5–9] and in spatially-structured microcosms
[10]. In each setting, the emergence and persistence of polymor-
phism in the absence of sexual recombination requires that
cohabitants opportunistically exploit unoccupied niche space,
and/or accept trade-offs between being a specialist and a
generalist [11–13]. In serial dilution batch culture, multiple
growth parameters can come under selection [14]: different clones
may arise having reduced lag time, increased maximum specific
growth rate, or enhanced capacity to survive at high cell densities
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in the presence of low nutrients [15]. Periodic changes in
population density and nutrient levels may bring balancing
selection to bear on these different phenotypes (e.g., [8]), especially
if mutations are antagonistically pleiotropic [16,17]. In spatially
structured environments selection may favor mutants better
adapted to particular regions or better able to colonize microhab-
itats formed at the boundaries between such regions. By contrast,
in continuous nutrient-limited environments, theory predicts that
selection will favor clones better able to scavenge the limiting
resource or more efficiently convert that resource to progeny
[18,19]. Ultimately, the outcome of the ‘evolutionary play’ in any
of these ‘ecological theaters’ (sensu [20]) will depend on founder
genotype, mutation rate, the complexity of genetic pathways
leading to different adaptive strategies, as well as pleiotropy [21]
and epistatic interactions [22].
Increasing evidence points to the possibility of not one, but three
potential outcomes when asexual microbes evolve in simple
environments: clonal succession, where a population is successively
swept by clones of higher fitness arising in the dominant lineage
[23,24]; clonal interference, where fixation of a single fittest clone is
deferred because independent beneficial mutations arise in
multiple, independent clones that compete with one another and
reduce each other’s fitness [25–27], and what we propose to call
clonal reinforcement, where the emergence of one genotype favors the
emergence and persistence of other genotypes via cooperative
interactions. Because cooperation is now recognized to be at least
as important as competition in driving biological innovation and in
structuring communities [28,29], we investigated the genetic and
environmental factors that foster interdependence in an evolving
lab population.
Previously [30], we examined the transcriptomes of an
experimentally evolved E. coli community in which three different
strains that arose from a common ancestor stably coexisted in a
simple, unstructured environment through metabolic cross-feeding
[3,31]. This system is unusual in that it clearly involves symbiotic
interactions among ecotypes that co-evolved in the absence of
spatial or temporal variation. Remarkably, the community’s
expression profile did not proportionately represent the sum of
each strain’s expression profile grown singly under evolutionary
conditions, indicating that the whole was not the sum of its parts.
Instead, expression data suggested that consumption of one
ecotype’s overflow metabolites by the others relieved feedback
inhibition, adding a layer of complexity to the evolved clones’
interactions. Using a candidate gene approach we identified two
mutations in the ancestral strain that may have predisposed clonal
reinforcement [30]. To better understand how physiological
performance and expression profile map onto genotype, and to
identify the molecular basis of community interactions we
sequenced the genomes of each of the three community members
and their common ancestor. We found unexpectedly high levels of
genetic variation in the three-membered community as a whole
and the numerically dominant strain in particular, as well as a
strong mutational bias due to specific lesions in DNA repair. The
dominant community member is a hypermutator that excels at
acquiring glucose, but does so at the expense of carbon excreted as
overflow metabolites to which it has limited access; this trade-off
effectively opens up new niches for other genotypes. We
discovered a set of adaptive mutations in this clone that have
not been previously reported to co-occur in other E. coli
evolution experiments, specifically those that enhance glucose
acquisition and may serve to maintain redox balance, but may
also increase net flux to overflow metabolites under aerobic
conditions. Because this community member releases growth
substrates that are differentially accessible to other community
members, and because it shares only one SNP mutation with
these strains, we suggest that it acts as an engine generating
biodiversity, creating new metabolic niches, but not necessarily
the occupants themselves.
Results and Discussion
Description of the community
In previous publications [3,30,31] we described certain features
of a stable polymorphism that arose from a single clone during the
course of 765 generations of aerobic, glucose-limited culture at
30uC (D<0.20 hr21) (Table 1). The four clones isolated from this
population (CV101, C103, CV115 and CV116) were originally
distinguished by their differences in antibiotic resistance and
colony morphology, and later shown to exhibit strain-specific rates
of glucose uptake, residual metabolite concentrations and expres-
sion profiles. In reconstruction experiments performed under
evolutionary conditions CV101, CV103 and CV116 were shown
to stably coexist at frequencies of approximately 0.10, 0.65 and
0.025, respectively. Because CV115 was not stably maintained, the
interactions among CV101, CV103 and CV116 were studied
more intensively. Based on differences in glucose uptake and
residual substrate concentrations, and the fact that strains’ steady
state frequencies could be predictably altered by exogenously
increasing the concentrations of residual metabolites, we conclud-
ed that this community was sustained by positive density-
dependent interactions in the form of cross-feeding, in which the
numerically dominant strain CV103 best takes up the limiting
resource glucose, but excretes acetate and glycerol (and/or a
closely-related compound, glycerol 3-phosphate) (J. Adams
unpublished results). These two overflow metabolites are then
scavenged by CV101 and CV116, respectively. Transcriptional
profiling of each clone in monoculture relative to the common
ancestor, JA122, revealed gene expression differences among the
evolved isolates related to carbon metabolism and expression
differences specific to CV103 consistent with activation of stress
response pathways and loss of motility.
Author Summary
The variability of natural systems makes it difficult to
deduce how organisms’ genotypes manifest as pheno-
types, and how communities of interacting organisms
arise. Using laboratory experimental evolution we can
control this variation. We previously showed that a
population of E. coli that originated from a single clone
and was cultured in the presence of a single limiting
resource, evolves into a stable, three-membered commu-
nity, wherein one clone excretes metabolites that the
others utilize as carbon sources. To discern the genetic
factors at work in producing this outcome and to
illuminate the community’s physiology, we sequenced
the genomes of the ancestral and evolved clones. We
identified in the ancestor mutations that may have
predisposed evolution of cross-feeding. We found that
the lineages which gave rise to the community diverged
early on, and that the numerically dominant lineage that
best scavenges limiting glucose does so as a result of
adaptive mutations that enhance glucose uptake but favor
fermentative over respiratory pathways, resulting in
overflow metabolites. Because this clone produces sec-
ondary resources that sustain other community members,
and because it shares with them only one mutation, we
conclude that it is an ‘‘engine’’ generating diversity by
creating new niches, but not the occupants themselves.
Experimental Evolution of Cross-Feeding in E. coli
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Whole genome re-sequencing
As summarized in Table 2, 584 mutations (580 SNPs, two
insertions and two deletions) were identified among the four
evolved clones. This number is substantially higher than has been
previously reported for laboratory evolution experiments of similar
duration conducted under similar conditions [32]. A majority of
these mutations, 504 (86%), is in coding regions and 374 (64%) are
non-synonymous, while 428 (73%), are unique to CV103. Almost
all (99.7% (578)) SNPs are GCRTA transversions, suggesting
defects in DNA repair among all of the evolved isolates. Strong
transversion bias has been noted in other evolution experiments,
and is likely due to defective repair of oxidatively damaged G:C
base-pairs [32,33].
The community consists of lineages that diverged early
in the history of the experiment
Phylogenetic analyses of the whole genome sequences [30] show
that the dominant clone CV103 is part of a highly divergent
lineage, while CV115 and CV116 are very closely related to one
another, and share a common ancestor with CV101 (Fig. 1).
Indeed, as CV115 and CV116 differ by only two SNPs, one a
synonymous substitution (gutQ, A221A), the other C-terminal (ycaO
G546V), and because only CV101, CV103 and CV116 could be
stably maintained at steady state, we restrict most of our discussion
to these three clones. Remarkably, the evolved clones all share
only one SNP. Thus, it is likely that the CV103 and CV101/
CV115/CV116 lineages diverged from one another early in the
experiment and that stable co-existence of more than one lineage
was an early feature of the population. In fact, previous work
documented a variant similar to CV103 (small colony, ampicillin-
resistant) had risen to appreciable frequency by generation 340
[3]. This result is not unexpected, as subsequent to the
observations of Helling et al. 1987, a number of other reports
appeared showing that multiple genotypes can coexist in nutrient-
limited chemostats [34–38]. An unanticipated finding in our
experiments was the large number of SNPs that accumulated
along the CV103 branch.
Mutation rate varies among evolved strains and their
common ancestor
Fluctuation analyses performed on the ancestral strain, JA122,
the canonical E. coli strain K12 MG1655, and the four co-evolved
clones revealed that the founder strain, JA122, is a mutator whose
mutation rate is approximately thirty-fold higher than E. coli K12
MG1655 (Table 1). This observation can be explained by a
nonsense mutation in JA122 affecting the adenine glycosylase
mismatch repair enzyme MutY (L299*). Defects in MutY are
known to cause a GCRTA transversion bias [33,39] and have
been observed by others in glucose limited chemostat experiments
[40,41]. Evolved strains CV101, CV115 and CV116 all had
mutation rates similar to JA122, while CV103’s mutation rate was
almost 10-fold higher again (Table 1). This difference can be
attributed to a second mutation resulting in an amino acid
substitution (A56D) in the base-excision repair pathway DNA
glycosylase, MutM. Increased mutation rate has been shown to be
selected for in microbial evolution experiments performed under a
variety of conditions [33,41–45] where it can strongly influence
evolutionary dynamics [46]. The fitness of mutators need not
decrease over time; Maharjan et al. [47] recently showed that
mutators arising under glucose limitation gain fitness relative to
their ancestor as a result of adaptive mutations in, for example, rpoS
and mglD. Mutator lineages persisted because most of the other
mutations accumulating in their backgrounds were neutral in their
effect on fitness, deleterious mutations being purged as the lineages
evolved. A similar mechanism may be at work in our experiment,
with an appreciable number of mutations in CV103 being neutral.
Certain transcriptional units are repeatedly mutated
Given the large number of SNPs, we sought to determine
whether certain genes or transcription units carried multiple
Table 2. Types of Single Nucleotide Polymorphisms (SNPs)
and their distribution among evolved strains.
Total mutations 584
Insertions/deletions 4
SNPs 580
SNPs in coding regions 502 (86.6%)
SNPs causing missense mutations 335 (57.8%)
SNPs causing nonsense mutations 39 (6.7%)
G to A transitions 1 (0.2%)
C to T transitions 1 (0.2%)
G to T transversions 293 (50.5%)
C to A transversions 285 (49.1%)
doi:10.1371/journal.pgen.1004430.t002
Figure 1. Phylogeny of strains based on whole-genome sequence. 580 SNPs across all four genomes were used to reconstruct evolutionary
relationships between consortium members using maximum likelihood. The number of SNPs that distinguish each lineage are shown above each
branch in green.
doi:10.1371/journal.pgen.1004430.g001
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mutations, either because they had had been selected for or
because their inactivation allowed neutral mutations to accumu-
late. Overall, 52 transcription units and 37 individual genes
contained more than one SNP (Table S1). Twenty-five of the
single/multiple gene hits occur exclusively in strain CV103
(Table S1). Four of these (eno, maeA, malG and ptsI) are directly
involved in glucose uptake/metabolism suggesting that they
contribute to the superior glucose uptake kinetics of this clone.
Five CV103-specific substitutions affect flagellar synthesis: three
SNPs occur in fliM, which encodes a flagellar motor switch
protein, one occurs in fliF, which encodes the flagellar M ring
protein, and one occurs in fliH, which encodes another flagellar
biosynthesis protein. These findings are consistent with the
previously observed down-regulation of flagellar genes in CV103
and the fact this strain is non-motile [30]. When all of the evolved
isolates are considered, it is perhaps surprising that CV116,
thought to salvage excreted glycerol/glycerol phosphate from
CV103, has a number of mutations (10) in transcription units that
are also mutated in CV103 (Table S1). The same is not true for
CV101, the strain that salvages overflow acetate (Table S1).
While most of these SNPs are silent mutations, they could
plausibly affect RNA stability or translation. Of the non-silent
changes, particularly noteworthy are four mutations (three in
CV103 and one in CV116) that affect NADH:ubiquinone
oxidoreductase I, as well as additional mutations affecting genes
involved in anaerobic formate production and electron transfer
(Table S1). Because both CV103 and CV116 show enhanced
glucose uptake relative to CV101 and the ancestral strain (Table 1
and [3]), these changes may be shared features of an adaptive
response to rapid glucose consumption and concomitant overpro-
duction of NADH (discussed below).
Certain SNPs are associated with strain-specific
differences in transcription and/or translation
Because we previously observed significant differences in gene
expression among evolved isolates grown in monoculture [30], we
sought to identify SNPs that could explain these differences.
Because the great majority of these transcriptional differences were
manifest in CV103, we focused on genes that could directly or
indirectly regulate loci differentially expressed in this strain and on
the 428 genes associated with a SNP in CV103. The intersection
of these two gene lists yielded three global regulators that could
explain the majority of transcriptional differences between CV103
and the other evolved isolates: rpoD, csrA and sdiA. RpoD, the
housekeeping sigma factor, controls transcription of over 2,300
genes. The ancestor of the four evolved isolates, JA122, has an
amber nonsense mutation (E26*, GAGRTAG) in rpoD that likely
leads to reduced translation of RpoD, but not necessarily its
complete absence, as JA122 also carries the supE44 amber
suppressor. CV103 has an additional silent mutation in rpoD
(T459T, ACCRACA) that does not affect protein sequence but
may affect translation, as the mutant codon ACA is 30% less
common than the wild-type codon ACC [48]. The regulatory
protein CsrA favors gluconeogenesis and glycogen synthesis over
glycolysis. While the CV103 mutation in csrA is also silent (G27G,
GGCRGGA), the resulting codon change is from one that is
common (f = 0.40) to one that is rare (f = 0.09). Finally, sdiA
encodes an N-acylhomoserine-L-lactone receptor that functions in
quorum sensing. In CV103, a SNP is located 27 base-pairs
upstream of the sdiA transcriptional start site in a region that
encodes a small RNA, RNA0-361. The function of this sRNA is
unknown, but it has been repeatedly identified in screens for small
RNAs that interact with the global RNA chaperone, Hfq [49,50],
in which CV103 has a missense mutation (see below).
Mutations that alter glucose transport: The outer
membrane
(Fig. 2) In earlier work we showed that all evolved isolates were
better able to scavenge limiting glucose than their common
ancestor [31], and that strain CV103 had a significantly higher
rate of glucose uptake than the other evolved isolates [3]. We later
attributed these observations to increased expression of LamB
glycoporin in all four strains relative to JA122 [51], and
significantly higher transcription of lamB in CV103 relative to
CV101, CV115 and CV116 [30]. In other studies of adaptation
under glucose limitation elevated lamB expression has repeatedly
been tied to mutations that affect the regulation of the Mal operon,
specifically mutations that affect expression of the lamB regulators
Mlc and/or MalT [35,51,52]. While we previously found that
CV101, CV115 and CV116 share a mutation in malT that could
up-regulate lamB expression, this mutation did not occur in CV103
[30], the strain that best scavenges limiting glucose.
Whole genome sequencing uncovered two other mutations in
CV103 that help explain higher transcript levels of lamB mRNA
and, by extension, its superior ability to scavenge limiting glucose.
The first mutation affects the gene for MalK, a negative regulator
of MalT [53]. Null mutations in malK promote constitutive mal/
lamB gene expression [54,55], presumably by disrupting the
MalK-MalT interaction. The malK SNP in CV103 causes an
amino acid change (D297E) in the C-terminal portion of the
protein that contains an important part of the MalT interaction
domain. Replacement of aa 297 is known to diminish the ability of
MalK to inhibit MalT [56], and thus the D297E SNP likely leads
to increased lamB transcription during glucose-limited growth [57–
60].
The second CV103 mutation that may influence lamB
expression occurs in the gene for the RNA chaperone Hfq. Hfq
is a global regulator that facilitates binding of small regulatory
RNAs (sRNAs) to mRNAs and by doing so affects translation and/
or degradation of those transcripts [61,62]. Details are scant as to
how most of these sRNAs regulate their targets and how Hfq
enhances or attenuates their activity, but the profound effect these
interactions can have on key cellular processes is being increasingly
recognized [61,63]. Hfq interacts with the mRNA of the E. coli
stationary phase sigma factor, RpoS, and is required for efficient
translation of RpoS mRNA [64]. Reduced RpoS expression has
been extensively studied as a key adaptation to continuous glucose-
limitation [40,65,66], and Hfq has recently been identified as an
alternative mutational target under glucose limitation in rpoS+
strains [67,68]. In these isolates, a missense mutation in Hfq
enhances glucose uptake via PtsG, increases levels of LamB, and
apparently reduces the amount of functional RpoS, resulting in
lower biomass yield. The hfq mutation in CV103, which results in
a Q52H substitution, could have similar effects: CV103 has
increased uptake of the glucose analog a-MG (Table 1), which
occurs exclusively via PtsG, increased LamB gene expression, and
decreased biomass yield relative to the other evolved clones [3,30].
Interestingly, the genomic context of the Hfq mutation in CV103
differs from those characterized by others in which defects in Hfq
have evolved in an rpoS deficient background [67,68]. CV103 and
our other evolved isolates share an ancestral rpoS(Am) mutation
which likely allows some RpoS translation.
Mutations that alter glucose transport: The inner
membrane
(Fig. 2) After entry into the periplasm, glucose is actively
transported across the inner membrane using the glucose-specific
sugar phosphotransferase system (PTS). Mutations that upregulate
Experimental Evolution of Cross-Feeding in E. coli
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an alternative high-affinity glucose transporter, the galactose
transporter MglBAC, are frequently observed following prolonged
growth under glucose limitation [35,51,52]; in this regard, our
system is no exception. In fact, the only SNP shared by all of the
evolved isolates is in the operator sequence for the MglD repressor
(mglO, CRA, +3 bp relative to the end of mglD), consistent with
increased expression of the mglBAC transcription unit [30,35].
Because the rate of glucose uptake in CV103 exceeds that of the
other clones, we looked for mutations that might affect expression
or activity of other inner-membrane glucose transporters. CV103
has two mutations in ptsI, which encodes enzyme I of the E. coli
sugar phosphotransferase system. This protein is active in its
dimeric form and participates in glucose uptake by accepting a
phosphate group from phophoenolpyruvate (PEP) and passing it
via phosphocarrier protein Hpr to sugar-specific enzymes such as
PtsG, which then use phosphate to ‘‘charge’’ incoming sugars
(Fig. 2 and 3) [69,70]. The mutations in ptsI result in two amino
acid substitutions (A328S, M518I), both of which occur in the C-
terminal region responsible for binding PEP and dimerization.
These may be reasonably expected to alter PtsI activity [71,72]; aa
328 is close to two residues that are part of the PEP binding site
(R332 and D335), while aa 518 is close to C502, which is required
for phosphotransfer [73,74]. When ,PO4 is not passed along by
PtsI, there can be regulatory consequences: unphosphorylated
PtsG can bind the transcriptional regulator Mlc and prevent it
from negatively regulating expression of its targets which include
ptsG itself, manXYZ and malT [75–77]. Thus, these mutations could
also explain the up-regulation of manXYZ in CV103, and lead to
higher expression of the LamB glycoporin though derepression of
malT transcription [78]. PtsI has also been shown to interact directly
with other phospho-enzymes, notably acetate kinase (ackA), thus
mutations in this protein may also affect acetate excretion [79].
Mutations in central metabolism may contribute to
CV103’s superior performance and propensity to create
niches
Although glucose transport is increased in all evolved isolates
relative to their common ancestor, and especially so in CV103,
expression of many glycolytic genes is decreased (Fig. 4). This trend
has also been observed in yeast evolution experiments carried out
under glucose limitation, and may reflect the selective advantage of
an energy conservation strategy under low nutrient conditions [80].
Also, the hypermutator lineage that gave rise to CV103 accumulated
a number of mutations predicted to impact conversions in glycolysis,
fermentation, and the TCA cycle. Certain of these mutations likely
underlie CV103’s superior glucose uptake kinetics, but some may also
favor excretion of and restricted access to overflow metabolites, which
opens up new niches for other genotypes.
Interconversion of fructose-6-phosphate and fructose-
1,6-bisphosphate
In CV103, transcript levels of pfkB, which encodes PfkII, a
secondary enzyme that converts fructose-6-phosphate into
Figure 2. Gene expression and SNPs among loci that mediate glucose uptake. Several SNPs occur in or upstream of genes known or
suspected to be involved in glucose uptake. Loci shown in green have lower monoculture transcription levels in all evolved isolates compared to the
ancestor JA122, while loci shown in red have elevated monoculture transcript levels. Grey denotes no change in transcript level detected. Loci
depicted in blue have different gene expression levels depending on the strain tested, and for these genes, the normalized log2 expression ratios of
the evolved strain relative to JA122 are shown in the inset table (see Materials and Methods). Positive values indicate increased expression in the
evolved isolates while negative values denote decreased expression. SNPs thought to affect proteins involved in glucose transport are indicated by
stars with strain and mutation details as indicated. Consistent with strain representations in Figure 1 light blue stars indicate ancestral mutations
present in JA122, purple indicates SNPs in CV101, yellow indicates SNPs in CV103, green indicates those in CV115/116, brown indicates SNPs shared
by CV101/CV103/CV115/CV116 and pink denotes SNPs shared by CV101 and CV115/116.
doi:10.1371/journal.pgen.1004430.g002
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fructose-1,6,-bisphosphate, is more highly expressed in CV103
than in the other strains; CV103 also carries a missense mutation
in this gene (Q201H) (Fig. 4). It is unclear whether this mutation is
beneficial, as PfkII is thought to be responsible for less 5% of the
phosphofructokinase activity in E. coli [81]. However, PfkII can
also use tagatose-6-phosphate as a substrate [82]. CV103 has a
surprising number of differences compared to the other clones in
the expression and sequence of other genes in the galactitol/
tagatose-6-P glycolytic pathway, including downregulation of
gatZY (encoding tagatose-1,6-bisphosphate aldolase 2) and gatABC
(galactitol PTS permease) as well as a mutation in the gene for
GatY (G49*) (Table S2). As in a number of other K12-derived
strains, the gat operon is likely constitutively expressed in JA122
due to IS3E element insertion in the galactitol regulator
(GatR) gene [83]. Interestingly, increased expression of gat genes
has been observed in experiments where E. coli has been
evolved under lactulose and/or methyl-galactoside limitation
[12,84,85].
Enolase, responsible for the conversion of 2-phosphoglycerate
into phosphoenolpyruvate (PEP), has two mutations in CV103,
one silent and one missense (L60L, A37S) (Fig. 4 and Table S2).
Aside from the regulatory role played by its product, PEP, enolase
participates in the degradation of certain RNAs as part of the
degradosome [86]. In particular, enolase is needed to degrade ptsG
Figure 3. Gene expression and SNPs among loci that mediate glycerol and acetate uptake/metabolism. As in Figure 2, a green color
indicates that the gene has a lower transcription level in monoculture chemostats relative to the ancestor JA122. A red color denotes elevated
monoculture transcript levels while grey denotes no change in transcript level. Expression levels of loci that vary significantly in a strain-specific
manner are shown in blue; for these genes, the normalized log2 expression ratios of the evolved strain relative to JA122 are shown in the inset table
(for details see Materials and Methods). Positive values indicate increased expression in the evolved isolates while negative values denote decreased
expression. Transcript ratios for these genes, relative to the ancestor JA122 grown under identical conditions, are presented in the inset table. Stars
and corresponding text denote the location and type of particular SNPs. Consistent with strain representations in Figure 1, light blue stars indicate
ancestral mutations present in JA122, purple indicates SNPs present in CV101, yellow indicates SNPs in CV103, green indicates those in CV115/116,
brown indicates SNPs shared by CV101/CV103/CV115/CV116 and pink denotes SNPs shared by CV101 and CV115/116.
doi:10.1371/journal.pgen.1004430.g003
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mRNA when intracellular levels of G-6-P are high (i.e., during
phosphosugar stress) [86,87]. This interaction also involves the
sRNA SgrS, Hfq and Pnp (polynucleotide phosphorylase), in
which CV103 also has a substitution (P104Q) [50,87–89]
(Table S2). ptsG mRNA is not degraded when Hfq is mutated
[90], thus in CV103 the combined action of mutations in
enolase, Pnp and Hfq may increase longevity of ptsG
transcripts.
Figure 4. Gene expression and SNPs among loci that mediate glycolysis and fermentation. Mutations that may affect glycolysis and
fermentation are restricted to the glucose-scavenger CV103. Green denotes lower transcription level in monoculture chemostats relative to the
ancestor JA122. Red indicates higher transcript levels and grey denotes no transcript level change relative to JA122. Blue colored genes are those that
show variable expression; normalized log2 expression ratios of the evolved strain relative to JA122 are shown in the inset table (for details see
Materials and Methods). Positive values indicate increased expression in the evolved isolates while negative values denote decreased expression.
Stars and corresponding text denote the location and type of particular SNPs. Consistent with strain representations in Figure 1, light blue stars
indicate ancestral mutations present in JA122, purple indicates SNPs present in CV101, yellow indicates SNPs in CV103, green indicates those in
CV115/116, brown indicates SNPs shared by CV101/CV103/CV115/CV116 and pink denotes SNPs shared by CV101 and CV115/116.
doi:10.1371/journal.pgen.1004430.g004
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From pyruvate to acetyl CoA and/or acetate
Pyruvate is a major metabolite that sits at the branch point
between glycolysis, the TCA cycle and fermentation (Fig. 4).
Measurements of intracellular pyruvate indicated that all of the
evolved isolates had significantly less intracellular pyruvate than
their common ancestor under glucose-limited conditions, although
no significant differences in pyruvate concentration could be
detected among the evolved strains (Table S3).
The primary route for oxidation of pyruvate during aerobic
growth is pyruvate dehydrogenase (PDH), a three-enzyme
complex that catalyzes the conversion of pyruvate into acetyl-
CoA and contributes to the redox burden by transferring electrons
to NAD+ (Fig. 4 and 5). Protein profiling of CV103 suggested the
presence of a mutation in one of the three PDH enzymes, lpd,
severe enough to eliminate the corresponding spot on a 2D gel
[51]. Whole genome sequencing confirmed a missense mutation in
the CV103 lpd gene that results in an amino acid substitution
(F76L) in the N-terminal portion of the translated protein (Table
S2). Because this substitution occurs in the FAD binding domain,
it likely affects electron transfer from the reduced co-factor
FADH2 to NAD+. PDH specific activity in CV103 was previously
shown to be 2–3 fold lower than that in the other strains,
indicating that this mutation does indeed have a negative effect
[51]. Loss of lpd activity can lead to phenotypic changes consistent
with many of the unique characteristics of CV103. In a screen for
E. coli knockouts with extended lifespans, lpd null mutants were
identified that had extended survival compared to wild-type E. coli
K-12 MG1655 [91]. This enhanced survival was accompanied by
reduced growth rate, reduced stationary phase cell density,
reduced oxygen consumption, reduced respiration and increased
accumulation of extracellular acetate, many of which phenotypes
are exhibited by CV103 (Table 1, [3]).
Given that CV103 rapidly consumes glucose while excreting
acetate, it seems unusual that a mutation affecting the conversion
of pyruvate into acetyl-CoA would be retained in this strain. An lpd
knockout can still grow on glucose and produce acetate, but it does
so more slowly by using an alternate route to acetate, pyruvate
oxidase (PoxB) [92]. In an effort to determine whether CV103
might be using an alternate enzymatic pathway to convert
pyruvate into acetate, we compared gene expression and sequence
data for the three alternative pyruvate oxidation pathways:
pyruvate oxidase (POX), pyruvate:flavodoxin oxidoreductase
(PFOR) and pyruvate formate-lyase (PFL) (Fig. 5).
The POX pathway directly converts pyruvate into acetate
without concomitant ATP generation (Fig. 5). Nevertheless, this
pathway is active during growth on glucose and can substitute for
PDH if highly expressed [93]. In our system, expression of the
gene for POX (poxB) is downregulated in all four evolved isolates
relative to their common ancestor. This is not unexpected, as other
glycolytic genes are downregulated. However, CV103 has a
nonsense mutation at amino acid 14 of poxB (E14*) which, given its
position at the extreme N-terminus, is likely to completely
inactivate the protein. While the ancestral supE44 amber
suppressor might allow limited poxB translation to occur, it is
unlikely that the POX pathway produces an appreciable amount
of acetate in CV103.
A second gene involved in acetate excretion, ydbK is expressed
under both anaerobic and aerobic (albeit at very low levels)
conditions (Fig. 5), [94,95]. ydbK encodes PFOR, which catalyzes
the conversion of pyruvate into acetyl-CoA with concomitant
reduction of flavodoxin or ferredoxin [96]. Interestingly, both of
these reduced molecules can be used to re-activate oxygen
sensitive PFL (see below) [94]. CV103 carries a missense mutation
of unknown effect (R539L) in ydbK; however, because this ORF
was not represented on our expression array, its transcription level
is unknown.
Finally, acetyl Co-A can also be produced by the cleavage of
pyruvate by pyruvate formate-lyase (PFL). PFL activity is primarily
associated with the pflB gene but is also encoded by tdcE, ybiW and
pflD [97–99]. PFL is oxygen sensitive and thus the primary route
to acetyl-CoA under anaerobic conditions, but it is transcribed,
active and useful during microaerobiosis [100–103]. Moreover,
production of PFL requires a smaller anabolic investment than
production of PDH, and may thus be preferred under conditions
of nutrient stress [104]. Functional PFL requires both transcrip-
tional (regulated by FNR and ArcA/B) and post-translational
activation by the activating enzyme PflA or the alternate activator
YfiD [103,105]. Consistent with the downregulation of many
glycolytic genes, transcript levels of both the primary PFL (pflB)
and its activator (pflA) are also downregulated across all of the
evolved strains relative to the ancestor JA122. The gene for pflB is
unchanged, and pflA has a silent substitution in CV103 (L205L).
By contrast, transcript levels of the three alternate PFLs (tdcE,
ybiW, pflD) and their alternate activator yfiD are not altered in any
of the evolved strains relative to JA122, though CV103 has SNPs
in the genes that encode two of the alternate PFLs: YbiW (A469S)
and PflD (G513G) (Fig. 5).
Perturbations in pyruvate transformation are known to impact a
key state variable in central metabolism: cellular redox balance.
NADH accumulates in cells with high glycolytic flux because it
cannot be re-oxidized as fast as it is generated. This increased
redox ratio (NADH/NAD+) creates a cellular response reminis-
cent of anaerobiosis, stimulating the cell to direct pyruvate toward
overflow metabolites and leading to repression of TCA cycle genes
such as isocitrate dehydrogenase (icd) and citrate synthase (gltA)
[106]. Given the relatively rapid uptake of glucose and higher rate
of acetate production by CV103, stress in the form of high redox
ratio may have influenced the evolution of this strain. NAD+
regeneration typically occurs downstream of pyruvate either via
the TCA cycle or fermentation, but could also occur via the
conversion of DHAP into glycerol (see section on glycerol
metabolism below).
Mutations in CV103 likely diminish flux through aerobic
pathways
(Fig. 6) The TCA cycle consists of eight steps beginning with
the conversion of acetyl CoA to citrate and ending with the
conversion of malate to oxaloacetate. Expression profiling of each
evolved isolate showed that relative to their common ancestor,
levels of transcripts for proteins involved in three of these steps (a-
ketoglutarate dehydrogenase, succinate dehydrogenase and fuma-
rase) were upregulated across all evolved strains. At two other
steps, aconitase (acnB) and isocitrate dehydrogenase (icdA),
transcript levels were elevated in three of four strains, but reduced
in CV103. Whole-genome sequencing uncovered intergenic SNPs
in CV103 that could impact flux at the icd branch point
connecting the TCA cycle with the glyoxylate bypass. In the
ancestral strain, JA122, the negative regulator of the glyoxylate
bypass, iclR, has a promoter mutation that likely affects iclR
negative autoregulation, leading to higher expression and
concomitant repression of the glyoxylate shunt genes aceA, aceB
and aceK. AceK negatively impacts flux through isocitrate
dehydrogenase by phosphorylation, diverting carbon through
isocitrate lyase (aceA) and malate synthase (aceB) (Fig. 6; [107]).
Thus, in the ancestor increased IclR can reasonably be expected
both to decrease transcription of glyoxylate bypass enzymes and to
prevent inactivation of Icd by AceK. While CV101 and CV116
exhibit increased relative expression of icdA and acnB, CV103
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shows decreased expression of both, perhaps owing to a CRA
mutation that lies between the aceA and aceK open reading frames.
Cellular pyruvate levels have long been thought to modulate
TCA cycle flux, principally by modulating isocitrate deydrogenase
activity (Fig. 6, [108,109]). The CV103-specific mutations
described above may also affect the pool of pyruvate. lpd mutants
have been shown to increase Entner-Doudoroff and glyoxylate
shunt activities and to decrease TCA cycle activity [92], while poxB
null mutations have been shown to repress citrate synthase and
malate dehydrogenase, and to activate acs [110]. CV103 contains
mutations in the lpd FAD binding domain, which likely accounts
for the 2–3 fold reduction of its pyruvate dehydrogenase activity,
as well as a nonsense mutation at amino acid 14 of poxB (E14*) that
likely inactivates this protein (Table S2). Together these
mutations could be expected to impede flux through the TCA
cycle in CV103. Conspicuous among genes differentially expressed
between evolved strains and their ancestor, and among the evolved
strains themselves, were those encoding respiratory proteins that
have a high H+/O coupling ratio. When each was grown by itself
in glucose-limited chemostats, transcript levels for genes in the
cyoABCDE operon that encode cytochrome oxidase subunits were
significantly increased in CV101 and CV115/116, but signifi-
cantly decreased in CV103, relative to their common ancestor
JA122 [30].
Finally, CV103 also shows gene expression differences and
mutations affecting the respiratory chain. Under conditions of
nutrient stress, metabolic cost-benefit analyses predict E. coli will
shift from the more efficient but anabolically expensive NADH:u-
biquinone oxidoreductase I (nuoABCEFGHIJKLMN)/cytochrome
bo oxidase (cyoABCD) chain to the anabolically inexpensive
lower-yield NADH:ubiquinone oxidoreductase II (ndh)/cyto-
chrome bd oxidase (cydABX) pairing [104,111,112]. Compared
with JA122, expression of nuoGHIJKL is 1.1-fold lower in CV103
but 1.3 to 1.5-fold higher in CV101, CV116 and CV115.
Similarly, transcript levels of cyoABC are 2.1-fold lower in CV103
and 1.3 to 1.9-fold higher in the other evolved strains. As noted,
CV103 also has missense mutations that affect NuoM (L336F) and
NuoI (R93L) as well as a silent substitution in NuoE (L14L). The
effect of these differences in expression and sequence of NDH-I
and cytochrome bo oxidase is unknown, but they may impact
cellular redox balance.
In summary, by considering the whole genome sequencing data
in the light of transcriptome [30], proteome [51], and phenotype
data [31] a coherent picture emerges of the dominant clone,
CV103, being highly fermentative but impaired in aerobic
pathways, resulting in the production of overflow metabolites,
which in the case of acetate creates a redox imbalance, but in the
case of glycerol/glycerol phosphate, may provide a means to
correct this imbalance. Because the other consortium members,
like their common ancestor, are respiro-fermentative they are
capable of exploiting the new biochemical niches created by
CV103.
The genetics of clonal reinforcement
(Fig. 3) We previously showed that differential production and
scavenging of acetate, glycerol and/or glycerol phosphate
explained stable coexistence of multiple genotypes under glucose
limitation [31,36]. Concerning acetate, whose excretion by CV103
supports growth of CV101, whole genome re-sequencing con-
firmed previously identified mutations in CV101 that up-regulate
Figure 5. Distribution of SNPs in pathways that mediate pyruvate catabolism. Several SNPs were detected in genes involved in the
conversion of pyruvate into acetate/acetyl Co-A in CV103. The four routes with their respective cofactors are shown on the left. Genes involved in the
conversion are shown on the right with asterisks denoting those genes that have a SNP in CV103. Stars and corresponding text denote the location
and type of particular SNPs. Consistent with strain representations in Figure 1 light blue stars indicate ancestral mutations present in JA122, purple
indicates SNPs present in CV101, yellow indicates SNPs in CV103, green indicates those in CV115/116, brown indicates SNPs shared by CV101/CV103/
CV115/CV116 and pink denotes SNPs shared by CV101 and CV115/116.
doi:10.1371/journal.pgen.1004430.g005
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acetyl CoA-synthetase (Acs) and the acetate transporter ActP, as
well as an ancestral mutation shared by the other clones that
prevents efficient re-uptake of acetate by disrupting a CRP
regulatory site in the acs promoter [30]. No additional mutations
affecting acetate excretion or uptake were found in any of the
evolved strains’ genomes, so it is likely that these two alone explain
the ability of CV101 to cross feed on the acetate produced by
CV103.
Regarding glycerol and/or glycerol phosphate, previous exper-
iments had shown that chemostat-grown CV116 assimilate
radiolabeled glycerol 50% faster than all other strains, and that
when CV116 and CV103 were co-cultured under glucose
limitation, the addition of exogenous glycerol [31] or glycerol 3-
phosphate caused the frequency of CV116 to increase. All of the
evolved strains carry an ancestral mutation (G55A) in the DNA-
binding transcriptional repressor, GlpR, that renders it constitu-
tively inactive [113]. We also discovered a CV116-specific SNP in
glpK encoding glycerol kinase, the first step in glycerol assimilation
(Table S2), though this is a silent substitution at a site (G232G;
GGCRGGA) not currently known to be associated with glpK
regulation. Transcriptional profiling of GlpR regulated genes
showed that the transcription unit containing glycerol kinase
(glpFKX) remained at ancestral levels, while genes for the glycerol-
3-phosphate:phosphate antiporter GlpT (glpT), and the divergently
transcribed anaerobic glycerol-3-phosphate dehydrogenase genes
(glpABC) were upregulated across all isolates relative to their
common ancestor [30].
The absence of differences in glp gene expression between
CV103 and CV116 led us to explore the possibility that glycerol
and/or glycerol phosphate cross-feeding might be mediated by
other mechanisms controlling the assimilation and production of
these metabolites. For example, post-transcriptional regulation in
CV103 could explain why JA122, CV101 and CV116 have three-
fold higher specific activity of glycerol kinase, and two-fold higher
specific activity of glycerol-3-phoshate dehydrogenase than CV103
[31]. GlpK is known to be post-transcriptionally inactivated by the
unphosphorylated version of the glucose-specific PTS enzyme
IIAGlc (crr), or by an excess of the effector molecule fructose-1,
Figure 6. Gene expression and SNPs among loci in the TCA cycle and glyoxylate shunt. Loci that are part of the TCA cycle are associated
with SNPs in CV103, CV115/CV116 and the ancestor JA122. Transcriptional profiling SAM analysis shows that many of the TCA cycle genes are up-
regulated in the evolved strains relative to their comon ancestor, while two genes that control the TCA/glyoxylate switch point (icd, acnB) are
expressed at a lower level in CV103. Blue colored genes are those that show variable expression among strains; normalized log2 expression ratios of
the evolved strain relative to JA122 are shown in the inset table (for details see Materials and Methods). Color coding and symbols are the same as for
Figures 2–5. Stars and corresponding text denote the location and type of particular SNPs. Consistent with strain representations in Figure 1 light
blue stars indicate ancestral mutations present in JA122, purple indicates SNPs in CV101, yellow indicates SNPs in CV103, green indicates those in
CV115/116, brown indicates SNPs shared by CV101/CV103/CV115/CV116 and pink denotes SNPs shared by CV101 and CV115/116.
doi:10.1371/journal.pgen.1004430.g006
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6-bisphosphate [114–116]. As described above, IIAGlc is phos-
phorylated via its interaction with the sugar non-specific EI (ptsI)/
HPr (ptsH) (Fig. 3). When glucose is transported through the inner
membrane by the Enzyme IIGlc complex (ptsG/crr), IIAGlc (crr)
transfers its phosphate to IIBCglc (ptsG), which then phosphorylates
glucose to yield intracellular glucose-6-phosphate (reviewed in
[114]). High levels of unphosphorylated IIAGlc signal glucose
abundance, and inhibit enzymes needed for catabolism of
alternate carbon sources such as glycerol and glycerol phosphate.
Specifically, unphosphorylated IIAGlc is known to inhibit glycerol
kinase activity [114,115,117]. We have already noted two
mutations in CV103 ptsI, which, by impairing EI, could lead to
excess unphosphorylated IIAGlc, which would inhibit glycerol
kinase (Fig. 3), and thereby restrict CV103’s access to glycerol.
CV103 may also have an excess of another potent glycerol
kinase inhibitor: fructose-1,6-bisphosphate (FBP) [116,118]. We
previously noted that relative to JA122 and the other evolved
isolates, CV103 has enhanced expression of pfkB, which encodes
the minor FBP creating enzyme, and lower levels of fbp, which
encodes the reverse enzyme fructose bisphosphatase [30]. Whole-
genome sequencing revealed a missense mutation of unknown
effect in pfkB (Q201H). These distinctive features of CV103,
combined with its demonstrated capacity for enhanced glucose
transport and assimilation, may produce elevated levels of the
GlpK inhibitor, FBP, further impeding CV103’s ability to
assimilate glycerol.
To understand why CV103 might release glycerol and/or
glycerol phosphate as metabolic by-products, we examined the
transcript levels and sequences of genes encoding proteins involved
in their production (Fig. 3 and Fig. 7). Glycerol can be generated
by E. coli as either (1) a by-product of phospholipid synthesis from
sn-glycerol-3-phosphate, (2) an end-product of the detoxification of
dihydroxyacetone phosphate/methylglyoxal, or (3) via hydrolysis
of glycerol-1-phosphate [119]. CV103 has multiple mutations that
affect nearly every step of phospholipid biosynthesis (Fig. 7A).
While the number of SNPs suggests CV103 reaps some benefit
from altering phospholipid production, these mutations should
also have the effect of restricting glycerol and phospholipid
formation from glycerol-3-phosphate. The second route to
glycerol, detoxification of DHAP/methylglyoxal, is catalyzed by
the reversible glycerol dehydrogenase GldA (Fig. 7B). This
reaction is likely to be useful for a strain such as CV103 that is
consuming glucose at a high rate, because it prevents the buildup
of DHAP and subsequent production of toxic methylglyoxal and,
significantly, because it re-oxidizes NADH [119,120]. CV103 may
also have higher amounts of intracellular DHAP and methylgly-
oxal as a consequence of a non-synonymous mutation (A6D) in the
gene for glycerol-3-phosphate dehydrogenase GpsA, which favors
the production of DHAP from G3P (Fig. 3 and 7). No SNPs
affecting GldA were found, and gldA transcript levels were not up-
or downregulated in any of the isolates. The third mechanism for
the production of glycerol is via the activity of the enzyme YfbT.
YfbT catalyzes the conversion of glycerol-1-phosphate into
glycerol and its gene is truncated in CV103 (E22*), resulting in
a defect likely expected to increase the pool of glycerol phosphate
but not glycerol [121].
Figure 7. SNPs in genes involved phospholipid biosynthesis and that contribute to glycerol synthesis. Three possible routes to the
production of glycerol in E. coli are shown along with corresponding gene names and SNPs. CV103 carries mutations that affect (A) phospholipid
biosynthesis (B) the interconversion of glycerol-3-phosphate and glycerol and (C) the interconversion of glycerol-1-phosphate and glycerol. A red
color denotes elevated monoculture transcript levels while grey denotes no change in transcript level. Stars (w) and corresponding text denote the
location and type of particular SNPs. Consistent with strain representations in Figure 1 light blue stars indicate ancestral mutations present in JA122,
purple indicates SNPs in CV101, yellow indicates SNPs in CV103, green indicates those in CV115/116, brown indicates SNPs shared by CV101/CV103/
CV115/CV116 and pink denotes SNPs shared by CV101 and CV115/116.
doi:10.1371/journal.pgen.1004430.g007
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In short, there are multiple, non-mutually exclusive reasons to
explain why CV103 has both a diminished capacity to assimilate
glycerol as well as an increased propensity to produce glycerol
and/or glycerol phosphate as overflow metabolites.
Clonal reinforcement drives the evolution of
biocomplexity
Biocomplexity, here defined as stable co-existence of multiple
genotypes, can emerge in clonal populations evolving in environ-
ments that are spatially structured with respect to their physical
features [10,13] or temporally structured with respect to
availability of limiting nutrients [8,11,122]. Under these condi-
tions, the emergence of complexity can be explained in terms of
classical niche theory [123]. Biocomplexity can also emerge in
clonal populations evolving in simple, unstructured environments
where reproduction is continuously limited by a single resource
[3,25,47,124]. There, population genetic complexity can be
maintained by clonal interference, wherein competitive interac-
tions preclude fixation of a fittest genotype [25], or by clonal
reinforcement where one clone supports growth by others via the
excretion of metabolizable substrates [3]. Our results bear out
certain predictions arising from Mazancourt and Schwartz’s
resource ratio theory of cooperation [125]. In their model, two
species initially competing for two resources can evolve towards a
cooperative trading relationship one of whose emergent properties
is enhanced resource utilization. Conditions that favor this
outcome include low mortality, low resource levels and differential
efficiency between species at depleting limiting resources. Our
community evolved under similar conditions: clonal lineages
persisted for many generations under chronic resource limitation
and gained differential access to available resources. Two
differences between their model and our system are that our
population was founded by a single clone initially limited on one
resource, and that the mutations which gave one of its descendants
preferential access to that resource have pleiotropic effects that
favor production of secondary resources on which other clones can
thrive. As for when this genotype arose, we know by PCR analysis
that key CV103-specific mutations at malK, mutM, ptsI, hfq and lpd
are present in the earliest Helling et al. [3] population sample
archived (,350 generations) (data not shown).
Clonal reinforcement is driven by the genotype best able
to acquire the limiting resource
A category of mutations certain to prove beneficial under
nutrient limitation is one that favors increased uptake of the
limiting nutrient, in this case glucose. Levels of residual glucose in
steady state CV103 monocultures are significantly lower than in
those of the other evolved strains and their common ancestor [31],
consistent with CV103’s more rapid uptake of the non-metabo-
lizable glucose analogue a-MG [3] and its higher expression of
LamB glycoporin [51]. The amino acid substitution in MalK
(D297E) likely diminishes its ability to deactivate MalT and, by
extension, activates lamB expression. A mutation in Hfq (Q52H),
that may negatively affect translation of the stress response global
regulator RpoS, would enhance glucose scavenging via LamB and
PtsG [126,127].
The evolution of a superior resource acquisition strategy
results in trade-offs
Because glucose consumption in most organisms, including E.
coli, is greater under anaerobic than under aerobic conditions (e.g.,
[128] and refs within), and because enhanced glucose consump-
tion is an adaptive strategy selected for in glucose-limited
chemostats, it is perhaps not surprising that, relative to the other
evolved clones and their common ancestor, the metabolic profile
of CV103 appears to be fermentative. Multiple lines of evidence
support this interpretation: (i) TCA cycle genes encoding aconitase
(acnB) and isocitrate dehydrogenase (icd) are downregulated
(Fig. 6), (ii) expression of the cyoABCD operon encoding
cytochrome oxidase is reduced [30], (iii) multiple mutations
suggest CV103 is dealing with excess formate production (Table
S4), and (iv) steady state chemostats of CV103 contain appreciable
residual concentrations of overflow metabolites [3,31]. While we
found no CV103-specific mutations that would constitutively
repress aerobic pathways, missense mutations at lpd and maeA, and
a nonsense mutation at poxB could be expected to diminish TCA
cycle flux. Moreover, increased glucose consumption by E. coli
under glucose limitation has been shown to repress both
respiration and the TCA cycle via changes in global regulators
such redox balance and pyruvate [106]. High glucose consump-
tion also strongly represses transcription of acs encoding acetyl
CoA synthetase [106], which helps to explain why no activity of
this acetate scavenging enzyme can be detected in CV103
monocultures [31], and why extracellular acetate is present at a
dilution rate (D = 0.2 h21) where none is expected. We therefore
conclude that CV103’s fermentative metabolism arises as a
consequence of selection for enhanced glucose consumption.
The CV103 lineage’s response to selection for enhanced glucose
consumption results in trade-offs that critically determine its role in
niche construction. At lower dilution rates E. coli growing under
aerobic glucose-limitation usually carries out a high-yield metab-
olism that converts all available glucose to CO2 ([129] and refs
therein). Indeed, under aerobic conditions the switch from
respiratory to respiro-fermentative metabolism typically occurs at
high growth rates and glucose concentrations, resulting in the
production of overflow metabolites such as acetate. (Under
anaerobic conditions, E. coli typically ferments all glucose to
CO2, acetate and ethanol [130].) The excretion of overflow
metabolites under conditions of restricted TCA flux creates an
imbalance in cellular redox, because acetate production in E. coli,
unlike ethanol production in yeast and lactate production in
animals, fails to regenerate NAD+ from the NADH formed by
glycolysis. In CV103 this problem may be further exacerbated by
mutations affecting pyruvate transformation, which would place
an additional premium on NAD+-generating processes, including
reactions that lead to glycerol and glycerol-3-phosphate produc-
tion. Concerning the apparent pleiotropic effects arising from
constitutively high glucose consumption in the CV103 back-
ground, it interesting to note that a recently discovered mechanism
to limit the production of overflow metabolites is to overexpress
the small RNA SgrS, which effectively reduces the rate of glucose
consumption [131]. SgrS, complexed with its binding partner,
diminishes cells’ ability to create new sugar transporters, in
particular PtsG [132]. In CV103 the binding partner of SgrS, Hfq,
has a missense mutation (Q52H), which may contribute to its
rapid uptake, but incomplete assimilation of glucose.
The glucose scavenging adaptations seen in CV103, which
contribute to its persistence and its ability to create new niches,
contrasts with metabolic adaptations commonly observed in
experimentally evolved yeast [21]. Yeast cultured at similar
dilutions rates adapt to aerobic glucose limitation by reversing
the Pasteur effect, switching from fermentative to respiratory
metabolism, which results in an enormous gain in their
reproductive output. While yeast evolution experiments typically
begin with populations that produce appreciable amounts of
overflow metabolites, mainly ethanol, strains quickly evolve a
metabolic strategy that produces essentially no residual carbon
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[21,133]. This difference in the adaptive trajectory followed by the
two species is grounded in fundamental differences in their
metabolism, which may preclude evolution of cross-feeding in
yeast cultured under glucose limitation.
The cost paid by one genotype to acquire the limiting
resource opens up new niches for others
Superior glucose consumption by the largely fermentative strain
CV103 helps to create multiple resources in an environment
where initially only one was limiting, thereby providing a selective
advantage to genotypes that can access those secondary resources.
The mechanism by which strain CV101 gains preferential access
to acetate is straightforward and relates to insertion of an IS30
element in the upstream regulatory region of acs encoding the
acetate-scavenging enzyme acetyl CoA synthetase [36]. The acs
locus is misregulated in the ancestral background due to a
mutation in the CRP binding site. Indeed, we observed
appreciable amounts of acetate in JA122 monocultures at steady
state [31], making it likely that selection pressure for acetate
scavenging existed at the outset of these experiments. This
pressure only increased with the advent of the CV103 lineage,
which evolved a superior mechanism for glucose consumption, but
which produces even more acetate because it retains the ancestral
defect, and because increased flux through fermentative pathways
represses acs transcription.
The basic CV103 phenotype is additionally supported by
mutations, in particular those related to pyruvate oxidation (e.g.
lpd), that accentuate changes in redox potential typical of
fermentative cells whose overflow metabolite is acetate. These
changes likely favor the formation of glycerol through side-
reactions whose dehydrogenase steps help regenerate NAD+.
CV116 has preferential access to this other metabolite because it
retains two ancestral mutations: one in acs that impairs acetate
scavenging, and another in glpR that constitutively derepresses
enzymes required for glycerol and glycerol phosphate assimilation.
By contrast, CV103 likely has limited access to these resources
because it has accumulated mutations in ptsI and pfkB, whose
downstream effects include inhibition of glycerol kinase, the rate-
limiting step in glycerol assimilation.
Reinforcement may underlie clonal diversity in the
laboratory and in nature
The evolution and persistence of multiple genotypes in a
population of asexual organisms supported by a single resource
seems to violate the principles of competitive exclusion [134,135]
and periodic selection [1,136]. Yet this phenomenon has now been
observed in a variety of simple experimental systems, in particular
those that are temporally [8,16] or spatially structured [10,13].
Although continuous nutrient-limited chemostats are unstructured
in both respects, a number of studies have now shown that
multiple bacterial lineages, some of them mutators, can arise and
coexist in a single chemostat vessel [3,35,38,47,52,137]. However,
none of these studies have provided evidence that biocomplexity
can arise and be sustained by means of the trading relationships we
call clonal reinforcement. We contend that this mechanism may be
quite common, as it is formally analogous to and may sometimes
be a precursor to syntrophy, a ubiquitous feature of natural
bacterial communities [138]. Clonal reinforcement may also be at
work in clinically relevant environments. For example, the
dominant clones in tumors are often fermentative, differing
markedly from normal (ancestral) tissue in their demand for O2
and nutrients, their production of CO2 (see [139] and refs therein),
and in their release of overflow metabolites that acidify the local
environment [140]. Such cells may create opportunities for
subpopulations to follow independent evolutionary trajectories
that lead to further genetic differentiation, perhaps even to
changes in their contact inhibition and drug resistance phenotypes.
Chronic bacterial infections are also genetically heterogeneous
[141], and can even be supported by syntrophic interactions [142].
We may therefore reasonably ask: to what extent does clonal
reinforcement enable subpopulations in tumors and chronic
infections to differentiate and become more resistant to chemo-
therapy and/or less visible to the immune system? The answers to
these questions have far-reaching implications.
Materials and Methods
Strains, media and culture conditions
Escherichia coli JA122, CV101, CV103, CV115 and CV116 were
maintained as permanent frozen stocks and stored at 280uC in
20% glycerol. Davis Minimal medium was used for all liquid
cultures with 0.025% glucose added for batch cultures and
0.0125% for chemostats [143]. Chemostat cultures were initiated
using colonies picked from Tryptone Agar (TA) plates and
outgrown in Davis minimal batch medium overnight. For
transcriptional profiling, total protein and metabolite assays
chemostats were maintained at 30uC with a dilution rate of
<0.2 h21 for approximately 70 hours (,15 generations). At the
end of each chemostat run, three aliquots of 50 mL culture were
rapidly filtered onto 0.2 mm nylon membranes, flash-frozen in
liquid nitrogen and stored at 280uC.
Mutation rate determination
Strains were streaked to colonies on LB agar overnight. Twelve
colonies were picked in their entirety for each strain and
inoculated into 3 mL of liquid LB, then grown overnight at
37uC. Subsequently, a portion of the liquid cultures was spread on
LB plates containing 300 mg mL-1 rifampicin. Colonies were
counted 48 h after spreading. To determine the titer, three
cultures for each strain were spread on LB agar plates at 1027,
1028 and 1029 dilutions. Colonies were counted and titers
determined as the average of the three 1028 dilutions. Mutation
rates per cell per generation were calculated using maximum
likelihood calculator FALCOR (http://www.keshavsingh.org/
protocols/FALCOR.html) [144].
Pyruvate assays
Following fast filtration and disruption by sonication intracel-
lular pyruvate was determined on chemostat-grown cells using the
Pyruvate Assay kit and PicoProbe (Biovision, Milpitas, CA, K609
and K317) as directed by the manufacturer’s guidelines. Estimated
values were normalized to cell protein, which was determined via
the Pierce BCA Protein Assay Kit (Cat. # 23227, Thermo
Scientific, Rockford, IL) using BSA as standard.
Transcriptional profiling
Global gene profiling was described in detail in a previous
publication [30]. Briefly, total RNA was extracted from triplicate
cultures of chemostat-grown JA122, CV101, CV103 and CV116
(D = 0.2 h21, 0.0125% glucose) and hybridized to full-length open
reading frame PCR products spotted onto aminosilane-coated
slides. Raw data was analyzed using TIGR MIDAS and MeV
software pipelines (www.tm4.org) and Significance Analysis of
Microarrays (SAM) [145] was used to examine expression
differences between strains using a multi-class comparison
consisting of four groups. Similarities among strains were identified
using one-class SAM and differences between the strains were
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examined using a 4-class SAM. d cutoffs were set at the 0% FDR
threshold (i.e. the highest d value that gave a median false
discovery rate of 0%). Average (mean) log2 ratios were calculated
after SAM analysis using Microsoft Excel and represent the
relative expression ratios of each evolved isolate compared to their
common ancestor.
Nucleic acid extraction
Genomic DNA for Illumina sequencing was extracted from cells
grown in batch culture using a modification of methods described
by Syn and Swarup [146]. Subsequent to DNA precipitation, spun
pellets were re-suspended in 1XTE (10 mM Tris, 1 mM EDTA,
pH 8.0) containing 50 mg/mL DNAse-free RNAse A and
incubated at 37uC for 30 minutes. Samples were re-extracted
once with phenol:chloroform (3:1), once with phenol:chloroform
(1:1) and twice with chloroform and then precipitated with EtOH
using standard techniques. Following re-precipitation, DNA was
dissolved in TE.
Illumina sequencing
Single-end 36 bp sequencing libraries were created using the
Illumina Genomic DNA Sample Prep Kit according to manufac-
turer’s instructions (5 mg input genomic DNA), and sequencing
flow cells were prepared using the Illumina Standard Cluster
Generation Kit. Samples were sequenced on the Illumina Genome
Analyzer II, and image analysis and data extraction were
performed using Illumina RTA 1.5.35.0. Reads (with qualities)
were aligned to the K12 reference genome (gi|49175990|r-
ef|NC_000913.2) using BWA v0.5.8 [147] with default parame-
ters. Whole-genome pileup files were generated using SAMtools
v0.1.8–18 [148] and single-nucleotide polymorphisms due to the
evolution were called using custom perl scripts that compared each
evolved strain with the original ancestor. Briefly, SNPs passed the
filter if they were represented in at least 40% of reads in the
evolved strain and at most 10% in the reference strain, with at
least 5 reads covering the position in both strains. Additional
heuristic filters included a confirming read from both strands, and
no more than one ambiguous SNP call (‘‘N’’) or deletion (‘‘*’’) at
that position. Insertions and deletions relative to the K12 reference
sequence were identified using Breseq v. 0.18 with default
parameters (http://barricklab.org/breseq; [32]).
Sanger sequencing
Thirty-seven SNPs identified by Illumina sequencing were
verified by Sanger sequencing. PCR products were generated
using Fermentas DreamTaq PCR Master Mix (Thermo Scientific,
Waltham, MA) following manufacturer’s instructions, treated with
ExoSAP-IT (Affymetrix, Santa Clara, CA) and sequenced on an
ABI3730XL machine by High Throughput Genomics Center
(Seattle, WA) (Table S5).
Supporting Information
Table S1 Genes and transcription units (T.U.) affected by more
than one mutation.
(PDF)
Table S2 All mutations.
(PDF)
Table S3 Intracellular pyruvate.
(PDF)
Table S4 Mutations associated with formate metabolism.
(PDF)
Table S5 SNP verification primers.
(PDF)
Acknowledgments
The authors gratefully acknowledge helpful discussions with Tom Ferenci
and Ivana Gudelj, thank Matt Herron and Karen Schmidt for critically
reading the manuscript, and Jacob Childress for assisting with fluctuation
tests.
Author Contributions
Conceived and designed the experiments: MK JW GS FR. Performed the
experiments: MK JW EK. Analyzed the data: MK JW EK GS FR.
Contributed reagents/materials/analysis tools: GS. Wrote the paper: MK
JW EK JA GS FR.
References
1. Muller HJ (1932) Some genetic aspects of sex. Am Naturalist 66: 118–138.
2. Williams GC (1975) Sex and Evolution. Princeton, NJ: Princeton University
Press.
3. Helling RB, Vargas CN, Adams J (1987) Evolution of Escherichia coli during
growth in a constant environment. Genetics 116: 349–358.
4. Ferenci T (2008) Bacterial physiology, regulation and mutational adaptation in
a chemostat environment. Adv Microb Physiol 53: 169–229.
5. Lang GI, Rice DP, Hickman MJ, Sodergren E, Weinstock GM, et al. (2013)
Pervasive genetic hitchhiking and clonal interference in forty evolving yeast
populations. Nature 500: 571–574.
6. Le Gac M, Brazas MD, Bertrand M, Tyerman JG, Spencer CC, et al. (2008)
Metabolic changes associated with adaptive diversification in Escherichia coli.
Genetics 178: 1049–1060.
7. Spencer CC, Bertrand M, Travisano M, Doebeli M (2007) Adaptive
diversification in genes that regulate resource use in Escherichia coli. PLoS
Genet 3: e15.
8. Rozen DE, Lenski RE (2000) Long-Term Experimental Evolution in
Escherichia coli. VIII. Dynamics of a Balanced Polymorphism. Am Nat 155:
24–35.
9. Turner PE, Souza V, Lenski RE (1996) Tests of Ecological Mechanisms
Promoting the Stable Coexistence of Two Bacterial Genotypes. Ecology 77:
2119–2129.
10. Rainey PB, Travisano M (1998) Adaptive radiation in a heterogeneous
environment. Nature 394: 69–72.
11. Herron MD, Doebeli M (2013) Parallel evolutionary dynamics of adaptive
diversification in Escherichia coli. PLoS Biol 11: e1001490.
12. Zhong S, Khodursky A, Dykhuizen DE, Dean AM (2004) Evolutionary
genomics of ecological specialization. Proc Natl Acad Sci U S A 101: 11719–
11724.
13. Rainey PB, Buckling A, Kassen R, Travisano M (2000) The emergence and
maintenance of diversity: insights from experimental bacterial populations.
Trends Ecol Evol 15: 243–247.
14. Rosenzweig F, Sherlock G (2011) Through a Glass, Clearly: Experimental
Evolution as a Window on Adaptive Genome Evolution. In: Garland JT, Rose
MR, editors. EXPERIMENTAL EVOLUTION: Concepts, Methods, and
Applications of Selection Experiments: University of California Press.
15. Novak M, Pfeiffer T, Lenski RE, Sauer U, Bonhoeffer S (2006) Experimental
tests for an evolutionary trade-off between growth rate and yield in E. coli. Am
Nat 168: 242–251.
16. Le Gac M, Plucain J, Hindre T, Lenski RE, Schneider D (2012) Ecological
and evolutionary dynamics of coexisting lineages during a long-term
experiment with Escherichia coli. Proc Natl Acad Sci U S A 109: 9487–
9492.
17. Rozen DE, Philippe N, Arjan de Visser J, Lenski RE, Schneider D (2009)
Death and cannibalism in a seasonal environment facilitate bacterial
coexistence. Ecol Lett 12: 34–44.
18. Monod J (1942) Recherche sur la croissance des cultures bacteriennes. Paris:
Hermann et Cie.
19. Kubitschek HE (1970) Introduction to Research with Continuous Cultures.
Englewood Cliffs, N.J: Prentice-Hall.
20. Hutchinson GE (1965) The Ecological Theater and the Evolutionary Play: Yale
University Press.
21. Wenger JW, Piotrowski J, Nagarajan S, Chiotti K, Sherlock G, et al. (2011)
Hunger artists: yeast adapted to carbon limitation show trade-offs under carbon
sufficiency. PLoS Genet 7: e1002202.
22. Kvitek DJ, Sherlock G (2011) Reciprocal sign epistasis between frequently
experimentally evolved adaptive mutations causes a rugged fitness landscape.
PLoS Genet 7: e1002056.
Experimental Evolution of Cross-Feeding in E. coli
PLOS Genetics | www.plosgenetics.org 15 June 2014 | Volume 10 | Issue 6 | e1004430
23. Novick A, Szilard L (1950) Experiments with the Chemostat on spontaneous
mutations of bacteria. Proc Natl Acad Sci U S A 36: 708–719.
24. Atwood KC, Schneider LK, Ryan FJ (1951) Periodic Selection in Escherichia
coli. Proc Natl Acad Sci U S A 37: 146–155.
25. Kao KC, Sherlock G (2008) Molecular characterization of clonal interference
during adaptive evolution in asexual populations of Saccharomyces cerevisiae.
Nat Genet 40: 1499–1504.
26. de Visser JA, Rozen DE (2006) Clonal interference and the periodic selection of
new beneficial mutations in Escherichia coli. Genetics 172: 2093–2100.
27. Gerrish PJ, Lenski RE (1998) The fate of competing beneficial mutations in an
asexual population. Genetica 102–103: 127–144.
28. Boucher DH, ed. (1985) The Biology of Mutualism. NY: Oxford University
Press.
29. Thompson JN (2005) The geographic mosaic of coevolution. Chicago, Illinois:
University of Chicago Press.
30. Kinnersley MA, Holben WE, Rosenzweig F (2009) E Unibus Plurum: genomic
analysis of an experimentally evolved polymorphism in Escherichia coli. PLoS
Genet 5: e1000713.
31. Rosenzweig RF, Sharp RR, Treves DS, Adams J (1994) Microbial evolution in
a simple unstructured environment: genetic differentiation in Escherichia coli.
Genetics 137: 903–917.
32. Barrick JE, Yu DS, Yoon SH, Jeong H, Oh TK, et al. (2009) Genome
evolution and adaptation in a long-term experiment with Escherichia coli.
Nature 461: 1243–1247.
33. Nghiem Y, Cabrera M, Cupples CG, Miller JH (1988) The mutY gene: a
mutator locus in Escherichia coli that generates G.C----T.A transversions. Proc
Natl Acad Sci U S A 85: 2709–2713.
34. Ferenci T (2003) What is driving the acquisition of mutS and rpoS
polymorphisms in Escherichia coli? Trends Microbiol 11: 457–461.
35. Notley-McRobb L, Ferenci T (1999) The generation of multiple co-existing
mal-regulatory mutations through polygenic evolution in glucose-limited
populations of Escherichia coli. Environ Microbiol 1: 45–52.
36. Treves DS, Manning S, Adams J (1998) Repeated evolution of an acetate-
crossfeeding polymorphism in long-term populations of Escherichia coli. Mol
Biol Evol 15: 789–797.
37. Maharjan RP, Gaffe J, Plucain J, Schliep M, Wang L, et al. (2013) A case of
adaptation through a mutation in a tandem duplication during experimental
evolution in Escherichia coli. BMC Genomics 14: 441.
38. Maharjan R, Seeto S, Notley-McRobb L, Ferenci T (2006) Clonal adaptive
radiation in a constant environment. Science 313: 514–517.
39. Lin JC, Singh RR, Cox DL (2008) Theoretical study of DNA damage
recognition via electron transfer from the [4Fe-4S] complex of MutY.
Biophysical journal 95: 3259–3268.
40. Notley-McRobb L, King T, Ferenci T (2002) rpoS mutations and loss of
general stress resistance in Escherichia coli populations as a consequence of
conflict between competing stress responses. J Bacteriol 184: 806–811.
41. Notley-McRobb L, Pinto R, Seeto S, Ferenci T (2002) Regulation of mutY and
nature of mutator mutations in Escherichia coli populations under nutrient
limitation. J Bacteriol 184: 739–745.
42. Cox EC (1976) Bacterial mutator genes and the control of spontaneous
mutation. Annu Rev Genet 10: 135–156.
43. Cox EC, Gibson TC (1974) Selection for high mutation rates in chemostats.
Genetics 77: 169–184.
44. Desai MM, Fisher DS (2011) The balance between mutators and nonmutators
in asexual populations. Genetics 188: 997–1014.
45. Gibson TC, Scheppe ML, Cox EC (1970) Fitness of an Escherichia coli
mutator gene. Science 169: 686–688.
46. de Visser JA (2002) The fate of microbial mutators. Microbiology 148: 1247–
1252.
47. Maharjan RP, Liu B, Li Y, Reeves PR, Wang L, et al. (2013) Mutation
accumulation and fitness in mutator subpopulations of Escherichia coli. Biol
Lett 9: 20120961.
48. Maloy SR, Stewart VJ, Taylor RK (1996) Genetic analysis of pathogenic
bacteria: A laboratory manual: Cold Spring Harbor Laboratory Press.
49. Raghavan R, Groisman EA, Ochman H (2011) Genome-wide detection of
novel regulatory RNAs in E. coli. Genome Res 21: 1487–1497.
50. Zhang A, Wassarman KM, Rosenow C, Tjaden BC, Storz G, et al. (2003)
Global analysis of small RNA and mRNA targets of Hfq. Mol Microbiol 50:
1111–1124.
51. Kurlandzka A, Rosenzweig RF, Adams J (1991) Identification of adaptive
changes in an evolving population of Escherichia coli: the role of changes with
regulatory and highly pleiotropic effects. Mol Biol Evol 8: 261–281.
52. Notley-McRobb L, Ferenci T (1999) Adaptive mgl-regulatory mutations and
genetic diversity evolving in glucose-limited Escherichia coli populations.
Environ Microbiol 1: 33–43.
53. Joly N, Bohm A, Boos W, Richet E (2004) MalK, the ATP-binding cassette
component of the Escherichia coli maltodextrin transporter, inhibits the
transcriptional activator malt by antagonizing inducer binding. J Biol Chem
279: 33123–33130.
54. Kuhnau S, Reyes M, Sievertsen A, Shuman HA, Boos W (1991) The activities
of the Escherichia coli MalK protein in maltose transport, regulation, and
inducer exclusion can be separated by mutations. J Bacteriol 173: 2180–2186.
55. Bukau B, Ehrmann M, Boos W (1986) Osmoregulation of the maltose regulon
in Escherichia coli. J Bacteriol 166: 884–891.
56. Bohm A, Diez J, Diederichs K, Welte W, Boos W (2002) Structural model of
MalK, the ABC subunit of the maltose transporter of Escherichia coli:
implications for mal gene regulation, inducer exclusion, and subunit assembly.
J Biol Chem 277: 3708–3717.
57. Notley L, Ferenci T (1995) Differential expression of mal genes under cAMP
and endogenous inducer control in nutrient-stressed Escherichia coli. Mol
Microbiol 16: 121–129.
58. Decker K, Peist R, Reidl J, Kossmann M, Brand B, et al. (1993) Maltose and
maltotriose can be formed endogenously in Escherichia coli from glucose and
glucose-1-phosphate independently of enzymes of the maltose system.
J Bacteriol 175: 5655–5665.
59. Raibaud O, Vidal-Ingigliardi D, Richet E (1989) A complex nucleoprotein
structure involved in activation of transcription of two divergent Escherichia
coli promoters. J Mol Biol 205: 471–485.
60. Raibaud O, Richet E (1987) Maltotriose is the inducer of the maltose regulon
of Escherichia coli. J Bacteriol 169: 3059–3061.
61. Vogel J, Luisi BF (2011) Hfq and its constellation of RNA. Nat Rev Microbiol
9: 578–589.
62. Valentin-Hansen P, Eriksen M, Udesen C (2004) The bacterial Sm-like protein
Hfq: a key player in RNA transactions. Mol Microbiol 51: 1525–1533.
63. Sobrero P, Valverde C (2012) The bacterial protein Hfq: much more than a
mere RNA-binding factor. Crit Rev Microbiol 38: 276–299.
64. Muffler A, Fischer D, Hengge-Aronis R (1996) The RNA-binding protein HF-
I, known as a host factor for phage Qbeta RNA replication, is essential for rpoS
translation in Escherichia coli. Genes Dev 10: 1143–1151.
65. Seeto S, Notley-McRobb L, Ferenci T (2004) The multifactorial influences of
RpoS, Mlc and cAMP on ptsG expression under glucose-limited and anaerobic
conditions. Res Microbiol 155: 211–215.
66. Notley-McRobb L, Seeto S, Ferenci T (2003) The influence of cellular
physiology on the initiation of mutational pathways in Escherichia coli
populations. Proc Biol Sci 270: 843–848.
67. Maharjan R, Zhou Z, Ren Y, Li Y, Gaffe J, et al. (2010) Genomic identification
of a novel mutation in hfq that provides multiple benefits in evolving glucose-
limited populations of Escherichia coli. J Bacteriol 192: 4517–4521.
68. Maharjan RP, Ferenci T (2013) Epistatic interactions determine the mutational
pathways and coexistence of lineages in clonal Escherichia coli populations.
Evolution 67: 2762–2768.
69. Patel HV, Vyas KA, Mattoo RL, Southworth M, Perler FB, et al. (2006)
Properties of the C-terminal domain of enzyme I of the Escherichia coli
phosphotransferase system. J Biol Chem 281: 17579–17587.
70. Postma PW, Lengeler JW, Jacobson GR (1993) Phosphoenolpyruvate:carbo-
hydrate phosphotransferase systems of bacteria. Microbiol Rev 57: 543–594.
71. Chauvin F, Fomenkov A, Johnson CR, Roseman S (1996) The N-terminal
domain of Escherichia coli enzyme I of the phosphoenolpyruvate/glycose
phosphotransferase system: molecular cloning and characterization. Proc Natl
Acad Sci U S A 93: 7028–7031.
72. Seok YJ, Lee BR, Zhu PP, Peterkofsky A (1996) Importance of the carboxyl-
terminal domain of enzyme I of the Escherichia coli phosphoenolpyruvate:
sugar phosphotransferase system for phosphoryl donor specificity. Proc Natl
Acad Sci U S A 93: 347–351.
73. Teplyakov A, Lim K, Zhu PP, Kapadia G, Chen CC, et al. (2006) Structure of
phosphorylated enzyme I, the phosphoenolpyruvate:sugar phosphotransferase
system sugar translocation signal protein. Proc Natl Acad Sci U S A 103:
16218–16223.
74. Garcia-Alles LF, Alfonso I, Erni B (2003) Enzyme I of the phosphotransferase
system: induced-fit protonation of the reaction transition state by Cys-502.
Biochemistry 42: 4744–4750.
75. Nam TW, Cho SH, Shin D, Kim JH, Jeong JY, et al. (2001) The Escherichia
coli glucose transporter enzyme IICB(Glc) recruits the global repressor Mlc.
Embo J 20: 491–498.
76. Lee SJ, Boos W, Bouche JP, Plumbridge J (2000) Signal transduction between a
membrane-bound transporter, PtsG, and a soluble transcription factor, Mlc, of
Escherichia coli. Embo J 19: 5353–5361.
77. Zeppenfeld T, Larisch C, Lengeler JW, Jahreis K (2000) Glucose transporter
mutants of Escherichia coli K-12 with changes in substrate recognition of
IICB(Glc) and induction behavior of the ptsG gene. J Bacteriol 182: 4443–
4452.
78. Decker K, Plumbridge J, Boos W (1998) Negative transcriptional regulation of
a positive regulator: the expression of malT, encoding the transcriptional
activator of the maltose regulon of Escherichia coli, is negatively controlled by
Mlc. Mol Microbiol 27: 381–390.
79. Fox DK, Meadow ND, Roseman S (1986) Phosphate transfer between acetate
kinase and enzyme I of the bacterial phosphotransferase system. J Biol Chem
261: 13498–13503.
80. Ferea TL, Botstein D, Brown PO, Rosenzweig RF (1999) Systematic changes
in gene expression patterns following adaptive evolution in yeast. Proc Natl
Acad Sci U S A 96: 9721–9726.
81. Kotlarz D, Garreau H, Buc H (1975) Regulation of the amount and of the
activity of phosphofructokinases and pyruvate kinases in Escherichia coli.
Biochim Biophys Acta 381: 257–268.
82. Babul J (1978) Phosphofructokinases from Escherichia coli. Purification and
characterization of the nonallosteric isozyme. J Biol Chem 253: 4350–4355.
Experimental Evolution of Cross-Feeding in E. coli
PLOS Genetics | www.plosgenetics.org 16 June 2014 | Volume 10 | Issue 6 | e1004430
83. Nobelmann B, Lengeler JW (1996) Molecular analysis of the gat genes from
Escherichia coli and of their roles in galactitol transport and metabolism.
J Bacteriol 178: 6790–6795.
84. Zhong S, Miller SP, Dykhuizen DE, Dean AM (2009) Transcription,
translation, and the evolution of specialists and generalists. Mol Biol Evol 26:
2661–2678.
85. Zhong S, Khodursky A, Dykhuizen DE, Dean AM (2004) Evolutionary
genomics of ecological specialization. Proc Natl Acad Sci U S A 101: 11719–
11724.
86. Morita T, Kawamoto H, Mizota T, Inada T, Aiba H (2004) Enolase in the
RNA degradosome plays a crucial role in the rapid decay of glucose transporter
mRNA in the response to phosphosugar stress in Escherichia coli. Mol
Microbiol 54: 1063–1075.
87. Vanderpool CK (2007) Physiological consequences of small RNA-mediated
regulation of glucose-phosphate stress. Curr Opin Microbiol 10: 146–151.
88. Morita T, Maki K, Aiba H (2005) RNase E-based ribonucleoprotein
complexes: mechanical basis of mRNA destabilization mediated by bacterial
noncoding RNAs. Genes Dev 19: 2176–2186.
89. Vanderpool CK, Gottesman S (2004) Involvement of a novel transcriptional
activator and small RNA in post-transcriptional regulation of the glucose
phosphoenolpyruvate phosphotransferase system. Mol Microbiol 54: 1076–
1089.
90. Ikeda Y, Yagi M, Morita T, Aiba H (2011) Hfq binding at RhlB-recognition
region of RNase E is crucial for the rapid degradation of target mRNAs
mediated by sRNAs in Escherichia coli. Mol Microbiol 79: 419–432.
91. Gonidakis S, Finkel SE, Longo VD (2010) Genome-wide screen identifies
Escherichia coli TCA-cycle-related mutants with extended chronological
lifespan dependent on acetate metabolism and the hypoxia-inducible
transcription factor ArcA. Aging Cell 9: 868–881.
92. Li M, Ho PY, Yao S, Shimizu K (2006) Effect of lpdA gene knockout on the
metabolism in Escherichia coli based on enzyme activities, intracellular
metabolite concentrations and metabolic flux analysis by 13C-labeling
experiments. J Biotechnol 122: 254–266.
93. Abdel-Hamid AM, Attwood MM, Guest JR (2001) Pyruvate oxidase
contributes to the aerobic growth efficiency of Escherichia coli. Microbiology
147: 1483–1498.
94. Blaschkowski HP, Neuer G, Ludwig-Festl M, Knappe J (1982) Routes of
flavodoxin and ferredoxin reduction in Escherichia coli. CoA-acylating
pyruvate: flavodoxin and NADPH: flavodoxin oxidoreductases participating
in the activation of pyruvate formate-lyase. Eur J Biochem 123: 563–569.
95. Eremina NS, Yampolskaya TA, Altman IB, Mashko SV, Stoynova NV (2010)
Overexpression of ydbK-encoding Putative Pyruvate Synthase Improves L-
valine Production and Aerobic Growth on Ethanol Media by an Escherichia
coli Strain Carrying an Oxygen-Resistant Alcohol Dehydrogenase. J Microbial
Biochem Technol 2: 077–083.
96. Akhtar MK, Jones PR (2009) Construction of a synthetic YdbK-dependent
pyruvate:H2 pathway in Escherichia coli BL21(DE3). Metab Eng 11: 139–147.
97. Sawers G, Hesslinger C, Muller N, Kaiser M (1998) The glycyl radical enzyme
TdcE can replace pyruvate formate-lyase in glucose fermentation. J Bacteriol
180: 3509–3516.
98. Reizer J, Reizer A, Saier MH, Jr. (1995) Novel phosphotransferase system
genes revealed by bacterial genome analysis–a gene cluster encoding a unique
Enzyme I and the proteins of a fructose-like permease system. Microbiology
141 (Pt 4): 961–971.
99. Pecher A, Blaschkowski HP, Knappe K, Bock A (1982) Expression of pyruvate
formate-lyase of Escherichia coli from the cloned structural gene. Arch
Microbiol 132: 365–371.
100. de Graef MR, Alexeeva S, Snoep JL, Teixeira de Mattos MJ (1999) The
steady-state internal redox state (NADH/NAD) reflects the external redox state
and is correlated with catabolic adaptation in Escherichia coli. J Bacteriol 181:
2351–2357.
101. Knappe J, Sawers G (1990) A radical-chemical route to acetyl-CoA: the
anaerobically induced pyruvate formate-lyase system of Escherichia coli. FEMS
Microbiol Rev 6: 383–398.
102. Sawers G, Bock A (1989) Novel transcriptional control of the pyruvate formate-
lyase gene: upstream regulatory sequences and multiple promoters regulate
anaerobic expression. J Bacteriol 171: 2485–2498.
103. Alexeeva S, de Kort B, Sawers G, Hellingwerf KJ, de Mattos MJ (2000) Effects
of limited aeration and of the ArcAB system on intermediary pyruvate
catabolism in Escherichia coli. J Bacteriol 182: 4934–4940.
104. Carlson RP (2007) Metabolic systems cost-benefit analysis for interpreting
network structure and regulation. Bioinformatics 23: 1258–1264.
105. Sawers G, Watson G (1998) A glycyl radical solution: oxygen-dependent
interconversion of pyruvate formate-lyase. Mol Microbiol 29: 945–954.
106. Vemuri GN, Altman E, Sangurdekar DP, Khodursky AB, Eiteman MA (2006)
Overflow metabolism in Escherichia coli during steady-state growth:
transcriptional regulation and effect of the redox ratio. Appl Environ Microbiol
72: 3653–3661.
107. Cozzone AJ, El-Mansi M (2005) Control of isocitrate dehydrogenase catalytic
activity by protein phosphorylation in Escherichia coli. J Mol Microbiol
Biotechnol 9: 132–146.
108. El-Mansi M, Cozzone AJ, Shiloach J, Eikmanns BJ (2006) Control of carbon
flux through enzymes of central and intermediary metabolism during growth of
Escherichia coli on acetate. Curr Opin Microbiol 9: 173–179.
109. el-Mansi EM, Nimmo HG, Holms WH (1986) Pyruvate metabolism and the
phosphorylation state of isocitrate dehydrogenase in Escherichia coli. J Gen
Microbiol 132: 797–806.
110. Li M, Yao S, Shimizu K (2007) Effect of poxB gene knockout on metabolism in
Escherichia coli based on growth characteristics and enzyme activities. World
Journal of Microbiology and Biotechnology 23: 573–580.
111. Carlson RP (2009) Decomposition of complex microbial behaviors into
resource-based stress responses. Bioinformatics 25: 90–97.
112. Weidner U, Geier S, Ptock A, Friedrich T, Leif H, et al. (1993) The gene locus
of the proton-translocating NADH: ubiquinone oxidoreductase in Escherichia
coli. Organization of the 14 genes and relationship between the derived
proteins and subunits of mitochondrial complex I. J Mol Biol 233: 109–122.
113. Elvin CM, Hardy CM, Rosenberg H (1985) Pi exchange mediated by the
GlpT-dependent sn-glycerol-3-phosphate transport system in Escherichia coli.
J Bacteriol 161: 1054–1058.
114. Deutscher J, Francke C, Postma PW (2006) How phosphotransferase system-
related protein phosphorylation regulates carbohydrate metabolism in bacteria.
Microbiol Mol Biol Rev 70: 939–1031.
115. Novotny MJ, Frederickson WL, Waygood EB, Saier MH, Jr. (1985) Allosteric
regulation of glycerol kinase by enzyme IIIglc of the phosphotransferase system
in Escherichia coli and Salmonella typhimurium. J Bacteriol 162: 810–816.
116. Zwaig N, Lin EC (1966) Feedback inhibition of glycerol kinase, a catabolic
enzyme in Escherichia coli. Science 153: 755–757.
117. de Boer M, Broekhuizen CP, Postma PW (1986) Regulation of glycerol kinase
by enzyme IIIGlc of the phosphoenolpyruvate:carbohydrate phosphotransfer-
ase system. J Bacteriol 167: 393–395.
118. Lin EC (1976) Glycerol dissimilation and its regulation in bacteria. Annu Rev
Microbiol 30: 535–578.
119. Subedi KP, Kim I, Kim J, Min B, Park C (2008) Role of GldA in
dihydroxyacetone and methylglyoxal metabolism of Escherichia coli K12.
FEMS Microbiol Lett 279: 180–187.
120. Applebee MK, Joyce AR, Conrad TM, Pettigrew DW, Palsson BO (2011)
Functional and metabolic effects of adaptive glycerol kinase (GLPK) mutants in
Escherichia coli. J Biol Chem 286: 23150–23159.
121. Lindner SN, Meiswinkel TM, Panhorst M, Youn JW, Wiefel L, et al. (2012)
Glycerol-3-phosphatase of Corynebacterium glutamicum. J Biotechnol 159:
216–224.
122. Rozen DE, Schneider D, Lenski RE (2005) Long-term experimental evolution
in Escherichia coli. XIII. Phylogenetic history of a balanced polymorphism.
J Mol Evol 61: 171–180.
123. Levine JM, HilleRisLambers J (2009) The importance of niches for the
maintenance of species diversity. Nature 461: 254–257.
124. Maharjan RP, Ferenci T, Reeves PR, Li Y, Liu B, et al. (2012) The multiplicity
of divergence mechanisms in a single evolving population. Genome Biol 13:
R41.
125. de Mazancourt C, Schwartz MW (2010) A resource ratio theory of
cooperation. Ecol Lett 13: 349–359.
126. Updegrove TB, Wartell RM (2011) The influence of Escherichia coli Hfq
mutations on RNA binding and sRNA*mRNA duplex formation in rpoS
riboregulation. Biochim Biophys Acta 1809: 532–540.
127. Updegrove T, Wilf N, Sun X, Wartell RM (2008) Effect of Hfq on RprA-rpoS
mRNA pairing: Hfq-RNA binding and the influence of the 59 rpoS mRNA
leader region. Biochemistry 47: 11184–11195.
128. Ko YF, Bentley WE, Weigand WA (1994) A metabolic model of cellular
energetics and carbon flux during aerobic Escherichia coli fermentation.
Biotechnol Bioeng 43: 847–855.
129. van Hoek MJ, Merks RM (2012) Redox balance is key to explaining full vs.
partial switching to low-yield metabolism. BMC Syst Biol 6: 22.
130. Tempest D, Neijssel O (1987) Growth Yield and Energy Distribution. In:
Neidhardt F, editor. Escherichia coli and Salmonella typhimurium Washington DC:
American Society for Microbiology. pp. 797–806.
131. Negrete A, Majdalani N, Phue JN, Shiloach J (2013) Reducing acetate
excretion from E. coli K-12 by over-expressing the small RNA SgrS.
N Biotechnol 30: 269–273.
132. Kawamoto H, Koide Y, Morita T, Aiba H (2006) Base-pairing requirement for
RNA silencing by a bacterial small RNA and acceleration of duplex formation
by Hfq. Mol Microbiol 61: 1013–1022.
133. Piotrowski JS, Nagarajan S, Kroll E, Stanbery A, Chiotti KE, et al. (2012)
Different selective pressures lead to different genomic outcomes as newly-
formed hybrid yeasts evolve. BMC Evol Biol 12: 46.
134. Gause GF (1932) Experimental studies on the struggle for existence: 1. Mixed
population of two species of yeast. Journal of Experimental Biology 9: 389–402.
135. Hardin G (1960) The competitive exclusion principle. Science 131: 1292–1297.
136. Crow JF, Kimura K (1965) Evolution in asexual populations. Am Nat 99: 439–
450.
137. Jezequel N, Lagomarsino MC, Heslot F, Thomen P (2013) Long-term diversity
and genome adaptation of Acinetobacter baylyi in a minimal-medium
chemostat. Genome Biol Evol 5: 87–97.
138. Morris BE, Henneberger R, Huber H, Moissl-Eichinger C (2013) Microbial
syntrophy: interaction for the common good. FEMS Microbiol Rev 37: 384–
406.
139. Seyfried TN, Shelton LM (2010) Cancer as a metabolic disease. Nutrition &
metabolism 7: 7.
Experimental Evolution of Cross-Feeding in E. coli
PLOS Genetics | www.plosgenetics.org 17 June 2014 | Volume 10 | Issue 6 | e1004430
140. Vaughan RA, Garcia-Smith R, Trujillo KA, Bisoffi M (2013) Tumor necrosis
factor alpha increases aerobic glycolysis and reduces oxidative metabolism in
prostate epithelial cells. Prostate 73: 1538–1546.
141. Ciofu O, Mandsberg LF, Bjarnsholt T, Wassermann T, Hoiby N (2010)
Genetic adaptation of Pseudomonas aeruginosa during chronic lung infection
of patients with cystic fibrosis: strong and weak mutators with heterogeneous
genetic backgrounds emerge in mucA and/or lasR mutants. Microbiology 156:
1108–1119.
142. Qin X, Zerr DM, McNutt MA, Berry JE, Burns JL, et al. (2012) Pseudomonas
aeruginosa syntrophy in chronically colonized airways of cystic fibrosis patients.
Antimicrob Agents Chemother 56: 5971–5981.
143. Helling RB, Kinney T, Adams J (1981) The maintenance of Plasmid-
containing organisms in populations of Escherichia coli. J Gen Microbiol 123:
129–141.
144. Sarkar S, Ma WT, Sandri GH (1992) On fluctuation analysis: a new, simple
and efficient method for computing the expected number of mutants. Genetica
85: 173–179.
145. Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays
applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116–
5121.
146. Syn CK, Swarup S (2000) A scalable protocol for the isolation of large-sized
genomic DNA within an hour from several bacteria. Anal Biochem 278: 86–90.
147. Li H, Durbin R (2009) Fast and accurate short read alignment with Burrows-
Wheeler transform. Bioinformatics 25: 1754–1760.
148. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, et al. (2009) The Sequence
Alignment/Map format and SAMtools. Bioinformatics 25: 2078–2079.
149. Adams J, Kinney T, Thompson S, Rubin L, Helling RB (1979) Frequency-
Dependent Selection for Plasmid-Containing Cells of ESCHERICHIA COLI.
Genetics 91: 627–637.
Experimental Evolution of Cross-Feeding in E. coli
PLOS Genetics | www.plosgenetics.org 18 June 2014 | Volume 10 | Issue 6 | e1004430
